ATAI

2.75

1.48% 0.04

Dopo l'orario di chiusura: 2.69 -0.06 -2.18%

Atai Life Sciences N V (ATAI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.71

Aprire:

$2.96

Volume 24 ore:

11.62M

Relative Volume:

5.72

Capitalizzazione di mercato:

$474.18M

Reddito:

$314.00K

Utile/perdita netta:

$-40.23M

Rapporto P/E:

-9.8214

EPS:

-0.28

Flusso di cassa netto:

$-84.71M

1 W Prestazione:

+25.00%

1M Prestazione:

+10.44%

6M Prestazione:

+71.87%

1 anno Prestazione:

+111.54%

Intervallo 1D:

$2.66

$2.96

Intervallo di 1 settimana:

$2.15

$2.96

Portata 52W:

$1.03

$2.96

Atai Life Sciences N V Stock (ATAI) Company Profile

Nome

Atai Life Sciences N V

Settore

Healthcare (1166)

Industria

Biotechnology (655)

Telefono

49 89 2153 9035

Indirizzo

WALLSTRASSE 16, BERLIN

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-11

Ultimi documenti SEC

ATAI's Discussions on Twitter

Confronta ATAI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATAI Atai Life Sciences N V	2.75	474.18M	314.00K	-40.23M	-84.71M	-0.28
VRTX Vertex Pharmaceuticals Inc	457.03	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.74	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	329.77	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	545.11	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	244.32	28.51B	3.81B	-644.79M	-669.77M	-6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-18	Reiterato	H.C. Wainwright	Buy
2024-04-03	Aggiornamento	Maxim Group	Hold → Buy
2022-11-01	Iniziato	Loop Capital	Buy
2021-11-30	Iniziato	Maxim Group	Buy
2021-11-11	Iniziato	ROTH Capital	Buy
2021-10-18	Iniziato	H.C. Wainwright	Buy
2021-09-01	Iniziato	Jefferies	Buy
2021-07-13	Iniziato	Berenberg	Buy
2021-07-13	Iniziato	Canaccord Genuity	Buy
2021-07-13	Iniziato	Cantor Fitzgerald	Buy
2021-07-13	Iniziato	Citigroup	Buy
2021-07-13	Iniziato	Cowen	Outperform
2021-07-13	Iniziato	Credit Suisse	Outperform
2021-07-13	Iniziato	RBC Capital Mkts	Sector Perform
2021-07-08	Iniziato	Aegis Capital	Buy

Mostra tutto

Atai Life Sciences N V Borsa (ATAI) Ultime notizie

Jun 18, 2025

ATAI Sees Potential Boost from U.S. Policy Shift on Psychedelics - GuruFocus

Jun 18, 2025

Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire

Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025

Jun 13, 2025

ATAI’s Stock Dilemma: ATAI Life Sciences N.V’s Market Performance and Outlook - investchronicle.com

Jun 13, 2025

SELLAS Life Sciences Group Inc (SLS) Stock: A Year of Highs and Lows - investchronicle.com

Jun 13, 2025

Jun 12, 2025

Atai Life Sciences (ATAI) Garnered a Buy Rating and $12 Target | ATAI Stock News - GuruFocus

Jun 12, 2025

Jun 09, 2025

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice - Yahoo Finance

Jun 09, 2025

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 09, 2025

Jun 07, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Jun 07, 2025

Jun 06, 2025

ATAI Gains Buy Rating and Price Target from Lucid Capital | ATAI Stock News - GuruFocus

Jun 06, 2025

Lucid Capital Markets initiates coverage on atai Life Sciences stock - Investing.com

Jun 06, 2025

Jun 05, 2025

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders - Business Wire

Jun 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders - Morningstar

Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock By Investing.com - Investing.com India

Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock - Investing.com

Jun 03, 2025

Atai in $370M merger deal with psychedelic drug specialist Beckley - BioWorld MedTech

Jun 03, 2025

Jun 02, 2025

atai Life Sciences (ATAI) Merges with Beckley Psytech for Psyche - GuruFocus

Jun 02, 2025

atai Life Sciences and Beckley Psytech merging - Seeking Alpha

Jun 02, 2025

Atai Life Sciences, Beckley Psytech to Merge in All-Stock Transaction - marketscreener.com

Jun 02, 2025

Transcript : Atai Life Sciences N.V., Beckley Psytech LimitedM&A Call - marketscreener.com

Jun 02, 2025

Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley - Bloomberg

Jun 02, 2025

ATAI and Beckley Psytech Plan Merger in Strategic All-Share Deal | ATAI Stock News - GuruFocus

Jun 02, 2025

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - Yahoo Finance

Jun 02, 2025

ATAI Life Sciences stock soars on Beckley Psytech merger deal By Investing.com - Investing.com UK

Jun 02, 2025

May 30, 2025

Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger - Mugglehead Magazine

May 30, 2025

May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences - Yahoo

May 29, 2025

May 27, 2025

2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com

May 27, 2025

May 24, 2025

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga

May 24, 2025

May 23, 2025